CIK: 0001281446 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 15, 2017
Total Value ($000): $503,510 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ADAMAS PHARMACEUTICALS INC | 2,601,351 | $45,524 | 9.0% | $18.31 | — | COM | 00548A106 |
| — | CONCERT PHARMACEUTICALS INC | 2,200,000 | $37,532 | 7.5% | $17.06 | — | COM | 206022105 |
| — | SYNERGY PHARMACEUTICALS DEL | 7,223,509 | $33,662 | 6.7% | $4.54 | — | COM NEW | 871639308 |
| VNDA | VANDA PHARMACEUTICALS INC | 2,232,238 | $31,251 | 6.2% | $10.87 | +31.1% | COM | 921659108 |
| — | RIGEL PHARMACEUTICALS INC | 9,105,691 | $30,140 | 6.0% | $3.31 | — | COM NEW | 766559603 |
| — | ZOGENIX INC | 2,440,959 | $26,484 | 5.3% | $11.56 | — | COM NEW | 98978L204 |
| — | IGNYTA INC | 3,071,300 | $26,413 | 5.2% | $5.55 | — | COM | 451731103 |
| — | THERAPEUTICSMD INC | 3,460,225 | $24,914 | 4.9% | $5.85 | — | COM | 88338N107 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 560,000 | $24,248 | 4.8% | $43.36 | -1.2% | COM | 64125C109 |
| — | SAGE THERAPEUTICS INC | 301,809 | $21,450 | 4.3% | $36.69 | — | COM | 78667J108 |
| — | SAGE THERAPEUTICS INC | 300,000 | $21,321 | 4.2% | $36.69 | — | Put | 78667J108 |
| — | FOAMIX PHARMACEUTICALS LTD | 3,681,708 | $18,224 | 3.6% | $8.36 | — | SHS | M46135105 |
| — | DBV TECHNOLOGIES S A | 485,915 | $17,114 | 3.4% | $35.48 | — | SPONSORED ADR | 23306J101 |
| — | AVEXIS INC | 200,000 | $15,206 | 3.0% | $41.71 | — | COM | 05366U100 |
| PTCT | PTC THERAPEUTICS INC | 1,468,521 | $14,450 | 2.9% | $12.10 | 0.0% | COM | 69366J200 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 250,000 | $12,813 | 2.5% | $41.87 | +10.4% | Call | 02043Q107 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 300,000 | $11,055 | 2.2% | $14.45 | — | COM | 37890U108 |
| — | PARATEK PHARMACEUTICALS INC | 539,571 | $10,387 | 2.1% | $19.25 | — | COM | 699374302 |
| — | ACORDA THERAPEUTICS INC | 432,500 | $9,083 | 1.8% | — | — | Put | 00484M106 |
| — | NEURODERM LTD | 314,724 | $8,356 | 1.7% | $26.55 | — | ORD SHS | M74231107 |
| — | BOVIE MEDICAL CORP | 3,055,000 | $8,157 | 1.6% | $2.83 | — | COM | 10211F100 |
| — | ACCELERON PHARMA INC | 300,000 | $7,941 | 1.6% | $26.47 | — | COM | 00434H108 |
| AUPH | AURINIA PHARMACEUTICALS INC | 1,000,000 | $7,340 | 1.5% | $4.62 | 0.0% | COM | 05156V102 |
| — | SUNESIS PHARMACEUTICALS INC | 1,537,873 | $6,305 | 1.3% | $4.14 | — | COM PAR | 867328700 |
| — | FIVE PRIME THERAPEUTICS INC | 155,265 | $5,613 | 1.1% | $36.15 | — | COM | 33830X104 |
| — | BLUEPRINT MEDICINES CORP | 122,129 | $4,884 | 1.0% | $39.99 | — | COM | 09627Y109 |
| — | MYOVANT SCIENCES LTD | 407,559 | $4,785 | 1.0% | $12.34 | — | COM | G637AM102 |
| — | CONNECTURE INC | 4,127,232 | $4,416 | 0.9% | $9.01 | — | COM | 20786J106 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 25,000 | $3,628 | 0.7% | $130.25 | 0.0% | SHS USD | G50871105 |
| — | AIMMUNE THERAPEUTICS INC | 122,455 | $2,661 | 0.5% | $21.73 | — | COM | 00900T107 |
| — | RADIUS HEALTH INC | 50,000 | $1,933 | 0.4% | — | — | Put | 750469207 |
| — | ACORDA THERAPEUTICS INC | 80,000 | $1,680 | 0.3% | — | — | Call | 00484M106 |
| — | CASCADIAN THERAPEUTICS INC | 377,900 | $1,565 | 0.3% | $4.14 | — | COM NEW | 14740B606 |
| — | TREVENA INC | 338,292 | $1,242 | 0.2% | $5.88 | — | COM | 89532E109 |
| — | ARADIGM CORP | 637,279 | $988 | 0.2% | $8.85 | — | COM NO PAR VALUE | 038505400 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 11,517 | $590 | 0.1% | $41.87 | +10.4% | COM | 02043Q107 |
| — | STREAMLINE HEALTH SOLUTIONS | 151,611 | $155 | 0.0% | $6.45 | — | COM | 86323X106 |